YHLO Joined Hands With Peking University In Molecular Diagnosis
Time Posted ：2024-04-03
Recently, YHLO has signed an agreement with Peking University (one of the historic and prestigious universities worldwide) to establish a collaborative laboratory for molecular diagnosis of infectious diseases to carry out R&D in the field of liver diseases diagnostics. This significant cooperation with Peking University will leverage the advantages of its medical disciplines and talents to conduct researches on molecular diagnosis of infectious diseases, which focuses on the latest technologies and innovative products in the IVD industry, which will make the joint lab an international advanced technology research and industrialization base.
View Details
YHLO received its first IVDR, paving the way for EU IVD market
Time Posted ：2024-04-03
In this October, YHLO proudly announced that it has received its first IVDR Certificate from BSI, one of the most reputable notified bodies under the In Vitro Diagnostics Regulation (IVDR). The certificate covers Anti-TPO—a Thyroid Peroxidase Antibody Assay Test Kit, PCT—A Procalcitonin Assay Test Kit and etc., which are applied to Chemiluminescence Immunoassay platform.
View Details
One more YHLO - Beckman Coulter joint automation system installed
Time Posted ：2024-04-03
Recently, another installation of YHLO iModules system with Beckman Coulter Power Express clinical lab automation systems was perfectly completed in the Sixth Hospital of Wuhan, Hubei Province, China. This integrated Total Laboratory Automation (TLA) will boost the efficiency of daily workload in the hospital's laboratory.
View Details
Great inheritance of YHLO iFlash Series, new product being installed
Time Posted ：2024-04-03
The newly launched YHLO iFlash family member, iFlash 9000, has caught much attention in China’s in vitro diagnostic market. In only a few days after launching, the first iFlash 9000 has been successfully installed and put into operation in a large class A hospital in Jiangsu Province, China.
View Details
YHLO Showcased Its Latest iFlash CLIA at MEDICA 2021
Time Posted ：2024-04-03
From 15-18 November, YHLO is making a grand exposure at MEDICA 2021, with its latest chemiluminescence immunoassay (CLIA) analyzer iFlash 1200, the bench-top analyzer iFlash 1800, the mono-test CLIA analyzer iStar 500, and total solutions for SARS-CoV-2 on exhibition.
View Details
World Pneumonia Day
Time Posted ：2024-04-03
World Pneumonia Day provides an annual forum for the world to stand together and demand action in the fight against pneumonia. More than 100 organizations representing the interests of children joined forces as the Global Coalition against Child Pneumonia
View Details
EU COVID-19 Rapid Antigen Tests Common List Inclusion of YHLO GLINE-2019-nCoV Ag
Time Posted ：2024-04-03
After being successfully granted official approval by the German PEI, YHLO’s rapid antigen test product GLINE-2019-nCoV Ag is officially listed on the EU COVID-19 Rapid Antigen Tests Common List on 8th December, 2021.
View Details
YHLO Receives FDA 510(K) Clearance for iFlash 1800 Chemiluminescence Immunoassay Analyzer and iFlash Total βhCG Assay
Time Posted ：2024-04-03
YHLO Biotech announced today that the iFlash 1800 Chemiluminescence Immunoassay Analyzer and iFlash Total βhCG Assay have received a 510(k) clearance from the U.S. Food and Drug Administration through a local partner. A 510(K) is a premarket submission made to FDA to demonstrate that the device to be marketed is as safe and effective, that is, substantially equivalent as predicate device. Receiving the 510(K) expands YHLO’s reach of iFlash 1800, as it has been installed in nearly 100 counties globally.
View Details
Add: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China
